AR054144A1 - Regimenes para anticonceptivos monofasicos orales - Google Patents

Regimenes para anticonceptivos monofasicos orales

Info

Publication number
AR054144A1
AR054144A1 ARP060102647A ARP060102647A AR054144A1 AR 054144 A1 AR054144 A1 AR 054144A1 AR P060102647 A ARP060102647 A AR P060102647A AR P060102647 A ARP060102647 A AR P060102647A AR 054144 A1 AR054144 A1 AR 054144A1
Authority
AR
Argentina
Prior art keywords
estrogen
ômö
estradiol
month
numerical
Prior art date
Application number
ARP060102647A
Other languages
English (en)
Inventor
Victoria Jane Davis
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34940210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR054144(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of AR054144A1 publication Critical patent/AR054144A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fertilizers (AREA)

Abstract

Regímenes para anticonceptivos orales monofásicos. Reivindicacion 1: Un método de anticoncepcion femenina humana el cual comprende: i) la administracion de una unidad anticonceptiva oral monofásica una vez al día, iniciando en la fecha numérica ôm+ 4ö de un mes continuadamente hasta la fecha numérica ômö del mes siguiente; y ii) no administrando la unidad anticonceptiva oral monofásica en las fechas numéricas entre ômö y ôm + 4ö; caracterizado porque ômö es una fecha numérica de un mes desde 1- 24 y donde el método es repetidamente llevado a cabo durante al menos dos ciclos. Reivindicacion 7: Un método de acuerdo con las reivindicaciones de la 1 a la 4, caracterizado porque la unidad de dosificacion comprende un estrogeno y un progestrogeno. Reivindicacion 8: Un método segun la reivindicacion 7, caracterizado porque el progestogeno es desogestrel o etonogestrel y el estrogeno es estradiol o una sal de él o un éster de él, o el estrogeno es etinilo estradiol. Reivindicacion 9: Un método segun la reivindicacion 7, caracterizado porque el progestogeno es nomegestrol acetato y el estrogeno es estradiol o una sal de él o un éster de él, o el estrogeno es etinilo estradiol.
ARP060102647A 2005-06-21 2006-06-21 Regimenes para anticonceptivos monofasicos orales AR054144A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05105484 2005-06-21

Publications (1)

Publication Number Publication Date
AR054144A1 true AR054144A1 (es) 2007-06-06

Family

ID=34940210

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102647A AR054144A1 (es) 2005-06-21 2006-06-21 Regimenes para anticonceptivos monofasicos orales

Country Status (18)

Country Link
US (1) US20080206310A1 (es)
EP (2) EP1898849A4 (es)
JP (1) JP2008543935A (es)
KR (2) KR20080023747A (es)
CN (1) CN101511336A (es)
AR (1) AR054144A1 (es)
AU (2) AU2006262546B2 (es)
BR (2) BRPI0612263A2 (es)
CA (2) CA2611813C (es)
EC (2) ECSP088098A (es)
MX (1) MX2007016233A (es)
NO (1) NO20076347L (es)
PE (1) PE20070344A1 (es)
RU (1) RU2008102074A (es)
TW (1) TW200727920A (es)
UA (1) UA95447C2 (es)
WO (2) WO2007001888A2 (es)
ZA (2) ZA200710862B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
AU2007274081B2 (en) * 2006-07-12 2012-08-02 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
AR066166A1 (es) 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
WO2010042612A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
CA2740002C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
US9192614B2 (en) * 2008-10-08 2015-11-24 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
CA2756222A1 (en) 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
WO2016156403A1 (en) 2015-03-31 2016-10-06 Merck Sharp & Dohme B.V. Vaginal ring applicator
CN113365634A (zh) * 2018-12-11 2021-09-07 卢品公司 超低剂量雌激素组合的药物递送系统及其方法和用途
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4736849A (en) * 1983-12-19 1988-04-12 Leonard Walter G Calendar-oriented pill dispenser
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
US5010055A (en) * 1986-06-24 1991-04-23 The General Hospital Corporation Use of EGF to reverse the contraceptive activity of MIS
US5185374A (en) * 1988-05-11 1993-02-09 K.K. Ueno Seiyaku Oyo Kenkyujo Use of 15-ketoprostaglandin E or F compounds for uterine contraction
DE4202636A1 (de) * 1992-01-30 1993-08-05 Foldenauer Willi Vorrichtung und verfahren zur kennzeichnung von daten des inhalts einer verpackung
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US6479475B1 (en) * 1996-07-26 2002-11-12 Wyeth Oral contraceptive
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US20020189141A1 (en) * 2001-06-14 2002-12-19 Kabushiki-Kaisha Musshu Calendar for administrating medicine as prescribed
US7017513B2 (en) * 2001-08-08 2006-03-28 Harry Giewercer Dosage reminder device and medication carton
WO2003082336A1 (en) * 2002-04-03 2003-10-09 Jencap Research Ltd. Female birth control method
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
PT1462107E (pt) * 2003-03-28 2009-01-02 Pantarhei Bioscience Bv Método contraceptivo feminino e kit para ser usado neste método
US20040222123A1 (en) * 2003-05-06 2004-11-11 Barr Laboratories, Inc. Kit for pharmaceuticals
US20050113350A1 (en) * 2003-11-26 2005-05-26 Bernd Duesterberg Extended use combination comprising estrogens and progestins
US20050149362A1 (en) * 2003-12-30 2005-07-07 Peterson Per A. System and method for visually presenting digital patient information for future drug use resulting from dosage alteration
US7381393B2 (en) * 2004-10-07 2008-06-03 The Regents Of The University Of California Process for sulfur removal suitable for treating high-pressure gas streams
US20060079491A1 (en) * 2004-10-08 2006-04-13 Andreas Sachse Method of female hormonal contraception using a fixed extended cycle hormonal preparation containing dienogest and ethinyl estradiol

Also Published As

Publication number Publication date
ZA200710865B (en) 2008-10-29
BRPI0612263A2 (pt) 2012-04-24
UA95447C2 (ru) 2011-08-10
ECSP088098A (es) 2008-02-20
WO2006138503A2 (en) 2006-12-28
PE20070344A1 (es) 2007-04-16
ECSP088097A (es) 2008-02-20
EP1898849A2 (en) 2008-03-19
EP1906968A2 (en) 2008-04-09
RU2008102074A (ru) 2009-07-27
US20080206310A1 (en) 2008-08-28
WO2007001888A2 (en) 2007-01-04
WO2006138503A8 (en) 2007-07-05
TW200727920A (en) 2007-08-01
CA2611813A1 (en) 2006-12-28
KR20080023747A (ko) 2008-03-14
KR20080025168A (ko) 2008-03-19
MX2007016233A (es) 2008-03-10
CN101511336A (zh) 2009-08-19
CA2611813C (en) 2013-10-15
JP2008543935A (ja) 2008-12-04
BRPI0612519A2 (pt) 2016-09-13
AU2006262546B2 (en) 2013-09-05
AU2006262546A1 (en) 2007-01-04
ZA200710862B (en) 2009-05-27
CA2611779A1 (en) 2007-01-04
EP1898849A4 (en) 2013-01-23
EP1906968A4 (en) 2013-04-10
WO2006138503A3 (en) 2009-05-14
NO20076347L (no) 2008-03-17
AU2006259344A1 (en) 2006-12-28
WO2007001888A3 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
AR054144A1 (es) Regimenes para anticonceptivos monofasicos orales
PE20051038A1 (es) Uso extendido de combinacion que comprende estrogenos y progestinas
Dhont History of oral contraception
ES2704999T3 (es) Tratamiento de hemorragia por disrupción en regímenes anticonceptivos hormonales prolongados
EP2585024B1 (en) Once-a-month method of contraception
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
ES2175650T3 (es) Anticonceptivos orales de dosis ultra baja con menos hemorragia menstrual y eficacia mantenida.
NZ545130A (en) Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
HUP0301813A2 (hu) Nem-orális androgén szteroidok
JP2013514984A5 (es)
BR0109334A (pt) Terapia de reposição hormonal
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
CR7420A (es) Composiciones farmaceuticas que comprenden uno o varios esteroides, uno o varios componentes de tetrahiidrofolatos y vitamina b12
PE20020425A1 (es) Metodo de anticoncepcion y forma de administracion del mismo
MX2007013137A (es) Regimen anticonceptivo con dosificacion de estrogeno ampliada.
WO2006042021A3 (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
NZ591627A (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
AR049197A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
TR200100234T2 (tr) Biyojen estrojensülfamatların hormon sübstitüsyon terapisinde kullanılması.
EA200301022A1 (ru) Гормональная заместительная терапия
ES2397983T3 (es) Procedimiento anticonceptivo oral multifásico de ciclo prolongado
AR049196A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
PE20070119A1 (es) Nuevos regimenes para dispositivos de suministro controlado de farmacos para la anticoncepcion
Johansson Future developments in hormonal contraception
AR049195A1 (es) Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento

Legal Events

Date Code Title Description
FB Suspension of granting procedure